News
TipRanks on MSN7h
AbbVie’s Promising Phase 3 Study on Upadacitinib for Alopecia AreataAbbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback